Mitochondrial Function and Dysfunction

Schapira, Anthony

In stock
Regular price 83.250 KD inc. VAT
License
Table of contents
  • Contentsvii
  • Contributorsxv
  • Prefacexix
  • SECTION I: MITOCHONDRIAL STRUCTURE AND FUNCTION1
  • Chapter 1. Mitochondrial DNA Structure and Function3
  • I. Mammalian Mitochondrial Genomes3
  • II. The Human mtDNA5
  • III. Structure of the Human mtDNA D-Loop Region7
  • IV. Mitochondrial DNA Replication7
  • V. Initiation of L-Strand DNA Replication9
  • VI. Alternative Mode of mtDNA Replication9
  • VII. General Features of Factors Associated with mtDNA Replication10
  • VIII. Regulation of mtDNA Replication11
  • IX. Mitochondrial Transcription12
  • X. Translation of Mitochondrial Transcripts15
  • XI. Concluding Remarks17
  • References17
  • Chapter 2. Oxidative Phosphorylation: Structure, Function, and Intermediary Metabolism25
  • I. Historical Background25
  • II. The Mitochondrial Electron Transport Chain27
  • III. Intermediary Metabolism45
  • IV. Concluding Remarks52
  • References52
  • Chapter 3. Import of Mitochondrial Proteins57
  • I. Introduction57
  • II. The Pathways of Mitochondrial Preprotein Import59
  • III. Mitochondrial Biogenesis and Human Neurodegenerative Diseases78
  • References82
  • SECTION II: PRIMARY RESPIRATORY CHAIN DISORDERS91
  • Chapter 4. Mitochondrial Disorders of the Nervous System: Clinical, Biochemical, and Molecular Genet93
  • I. Introduction94
  • II. Historical Considerations94
  • III. Genetics and Pedigree Studies98
  • IV. Clinical Features103
  • V. Important Clinical Questions105
  • VI. Major Mitochondrial Syndromes106
  • VII. Biochemical Features112
  • VIII. Diagnostic Approaches115
  • IX. Treatment of Mitochondrial Disorders123
  • References132
  • SECTION III: SECONDARY RESPIRATORY CHAIN DISORDERS145
  • Chapter 5. Friedreich’s Ataxia147
  • I. Features of Friedreich’s Ataxia147
  • II. Effect of FRDA Gene Mutations150
  • III. Models of FRDA152
  • IV. FRDA Molecular Mechanisms154
  • V. Therapeutic Intervention162
  • VI. Conclusion165
  • References167
  • Chapter 6. Wilson Disease175
  • I. The Role and Transport of Copper in Health175
  • II. Aceruloplasminemia and Menkes’ Disease177
  • III. Experimental Models of Wilson Disease178
  • IV. Mitochondrial Dysfunction in Animal Models179
  • V. Mitochondrial Dysfunction in Human Disease180
  • VI. Molecular Basis for the Variation in Phenotype182
  • VII. Diagnosis183
  • VIII. Cranial Magnetic Resonance Imaging (MRI) and Spectroscopy in Wilson Disease183
  • IX. Treatment185
  • X. Conclusion187
  • References187
  • Chapter 7. Hereditary Spastic Paraplegia191
  • I. Introduction191
  • II. Clinical Features192
  • III. Genetics193
  • References201
  • Chapter 8. Cytochrome c Oxidase Deficiency205
  • I. Cytochrome c Oxidase Biogenesis205
  • II. Nuclear Genes Affecting COX Assembly and Stability209
  • III. Nuclear Genes Affecting mtDNA Level and/or Stability221
  • IV. mtDNA Defects225
  • References233
  • SECTION IV: TOXIN-INDUCED MITOCHONDRIAL DYSFUNCTION241
  • Chapter 9. Toxin-Induced Mitochondrial Dysfunction243
  • I. Introduction243
  • II. Inhibitors of Mitochondrial Complex I: NADH Ubiquinine Oxidoreductase244
  • III. Inhibitors of Mitochondrial Complex II: Succinate Ubiquinol Oxidoreductase254
  • IV. Inhibitors of Mitochondrial Complex IV: Cytochrome c Oxidase258
  • V. Manganese260
  • VI. 3-Acetylpyridine262
  • VII. Myopathies and Myotoxic Agents264
  • VIII. Discussion: What Determines the Regional and Cellular Specificity of Mitochondrial Toxins?265
  • References267
  • SECTION V: NEURODEGENERATIVE DISORDERS281
  • Chapter 10. Parkinson’s Disease283
  • I. Introduction.283
  • II. Mitochondrial Dysfunction in Parkinson’s Disease284
  • III. Etiology of Parkinson’s Disease287
  • IV. Mitochondrial Dysfunction and the Pathophysiology of Parkinson’s Disease294
  • V. Concluding Remarks302
  • References.303
  • Chapter 11. Huntington’s Disease: The Mystery Unfolds?315
  • I. Huntington’s Disease315
  • II. Epidemiology and Symptomatology316
  • III. Neuropathology316
  • IV. Genetics317
  • V. Other Triplet Repeat Diseases318
  • VI. Intracellular Localization of Normal and Mutant Huntingtin.319
  • VII. Function of Normal and Mutant Huntingtin321
  • VIII. Cell Death in Huntington’s Disease: Apoptosis and Authophagy323
  • IX. Oxidative Stress and Metabolic Dysfunction324
  • X. Dopamine Toxicity.325
  • XI. Transgenic Mouse Models of Huntington’s Disease326
  • XII. Concluding Remarks328
  • References329
  • Chapter 12. Mitochondria in Alzheimer’s Disease341
  • I. Introduction342
  • II. Historical Overview and the Amyloid Cascade Hypothesis342
  • III. Metabolic Dysfunction in Alzheimer’s Disease has been Reported344
  • IV. Morphological Studies Demonstrate Mitochondrial Abnormalities in Alzheimer’s Disease345
  • V. PDHC and KGDHC in Alzheimer’s Disease345
  • VI. Brain Biochemical Studies of Mitochondrial Enzymes in Alzheimer’s Disease: Is Cytochrome Oxida346
  • VII. Is a Brain Cytochrome Oxidase De.ciency a Robust Feature of Alzheimer’s Disease?355
  • VIII. Studies of Cytochrome Oxidase in Non-CNS Tissues in Alzheimer’s Disease: Clues to the Origin356
  • IX. Cytochrome Oxidase Dysfunction in Alzheimer’s Disease: Possible Genetic Component?358
  • X. Cytochrome Oxidase Dysfunction in Alzheimer’s Disease: Genetic Studies are Still Inconclusive361
  • XI. Cybrid Data Suggest mtDNA Contributes to Alzheimer’s Disease Cytochrome Oxidase Dysfunction366
  • XII. Unresolved Issues in Alzheimers Disease Cybrid Studies: Where is the mtDNA Mutation?Ž371
  • XIII. Could a Cytochrome Oxidase Defect Cause Alzheimer’s Disease?372
  • XIV. Concluding Remarks373
  • References375
  • Chapter 13. Contributions of Mitochondrial Alterations, Resulting from Bad Genes and a Hostile Envir387
  • I. Overview of Neurodegenerative Cascades in Alzheimer’s Disease387
  • II. Mitochondrial Alterations in Alzheimer’s Disease Patients and Experimental Models389
  • III. Genetic Factors and Mitochondrial Alterations in Alzheimer’s Disease.394
  • IV. Environmental Factors and Mitochondrial Alterations in Alzheimer’s Disease397
  • V. Conclusions401
  • References401
  • Chapter 14. Mitochondria and Amyotrophic Lateral Sclerosis411
  • I. Introduction411
  • II. Clinical Features413
  • III. Pathogenic Hypotheses414
  • IV. Transgenic Mouse Models of ALS420
  • V. Conclusion423
  • References424
  • SECTION VI: MODELS OF MITOCHONDRIAL DISEASE427
  • Chapter 15. Models of Mitochondrial Disease429
  • I. Introduction430
  • II. Classification of mtDNA Defects Causing Respiratory Chain Disease431
  • III. Cell Models Employed to Study mtDNA Defects432
  • IV. Cell Models of Respiratory Chain Disease Associated with Speci.c mtDNA Defects434
  • V. Classification of Nuclear DNA Defects Causing Respiratory Chain Disease442
  • VI. Cell Models of Respiratory Chain Disease Associated with Nuclear DNA Defects445
  • VII. Application of Cell Models for the Development of Therapeutic Strategies in mtDNA Disease447
  • VIII. Animal Models of Respiratory Chain Disease449
  • IX. Other Models of Respiratory Chain Disease455
  • X. Conclusions457
  • References458
  • SECTION VII: DEFECTS OF β-OXIDATION INCLUDING CARNITINE DEFICIENCY467
  • Chapter 16. Defects of β-Oxidation Including Carnitine Deficiency469
  • I. Introduction469
  • II. Background Biochemistry470
  • III. Inherited Disorders of Mitochondrial β-Oxidation480
  • IV. Conclusions505
  • References505
  • SECTION VIII: MITOCHONDRIAL INVOLVEMENT IN AGING517
  • Chapter 17. The Mitochondrial Theory of Aging: Involvement of Mitochondrial DNA Damage and Repair519
  • I. Mitochondria: The Biological Clock?519
  • II. Oxidative Damage to Mitochondria520
  • III. Accumulation of Oxidative Damage to mtDNA522
  • IV. DNA Repair in Mammalian Mitochondria525
  • V. Changes in mtDNA Repair with Age528
  • VI. Conclusions530
  • References530
  • Index535
  • Contents of Recent Volumes549
Book details
  • Vendor Elsevier S & T
  • SKU 9780123668547
  • ISBN-13 9780080489070
  • Author Schapira, Anthony
  • Category Medical
  • Subject Neuroscience

Do you have questions about this book?

Ask an expert!

Mitochondria are critical to the survival of cells, therefore, it is not surprising that abnormalities in mitochondrial function may lead to human disease. This book concentrates on the biology and pathology of mitochondria, covering some ot the important basic science features of the biology of mitochondria. It then moves on to discuss the breadth of human diseases related to mitochondrial dysfunction, including Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Alzheimer's disease.

* Provides comprehensive coverage of basic science and clinical features of mitochondrial dysfunction
* Presents detailed analysis of "hot" topics in mitochondrial function and neurodegenerative diseases
* Includes outstanding list of contributing authors